Search

Cephia D Toomer

Examiner (ID: 3951, Phone: (571)272-1126 , Office: P/1771 )

Most Active Art Unit
1771
Art Unit(s)
1797, 1771, 1721, 1714, 1111
Total Applications
2905
Issued Applications
1874
Pending Applications
316
Abandoned Applications
715

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5661054 [patent_doc_number] => 20060251650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Antagonists of neuroplin receptor function and use thereof' [patent_app_type] => utility [patent_app_number] => 11/488364 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 17360 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251650.pdf [firstpage_image] =>[orig_patent_app_number] => 11488364 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/488364
Antagonists of neuropilin receptor function and use thereof Jul 17, 2006 Issued
Array ( [id] => 5079630 [patent_doc_number] => 20070122854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Method for diagnosing colon cancer' [patent_app_type] => utility [patent_app_number] => 11/291147 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4536 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122854.pdf [firstpage_image] =>[orig_patent_app_number] => 11291147 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/291147
Method for diagnosing colon cancer Nov 28, 2005 Abandoned
Array ( [id] => 386497 [patent_doc_number] => 07303866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/253190 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13452 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/303/07303866.pdf [firstpage_image] =>[orig_patent_app_number] => 11253190 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/253190
Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof Oct 16, 2005 Issued
Array ( [id] => 6977444 [patent_doc_number] => 20050287160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'HLA-A24 binding peptides of enhancer of zeste homolog 2' [patent_app_type] => utility [patent_app_number] => 11/208541 [patent_app_country] => US [patent_app_date] => 2005-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5770 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287160.pdf [firstpage_image] =>[orig_patent_app_number] => 11208541 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/208541
HLA-A24 binding peptides of enhancer of zeste homolog 2 Aug 22, 2005 Issued
Array ( [id] => 5766777 [patent_doc_number] => 20060018901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Use of antibodies in a very low dose for the vaccination against cancer' [patent_app_type] => utility [patent_app_number] => 11/185299 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7306 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018901.pdf [firstpage_image] =>[orig_patent_app_number] => 11185299 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/185299
Use of antibodies in a very low dose for the vaccination against cancer Jul 19, 2005 Abandoned
Array ( [id] => 5813147 [patent_doc_number] => 20060083743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Method of cancer therapy by in situ production of F5 antibodies' [patent_app_type] => utility [patent_app_number] => 11/143735 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 19264 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11143735 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/143735
Method of cancer therapy by in situ production of F5 antibodies Jun 2, 2005 Abandoned
60/813610 Preparation of a peptide compound (SYRAPRO-2000) and its use for the activation of protein phosphatase-2A1 enzyme May 3, 2005 Pending
Array ( [id] => 5793987 [patent_doc_number] => 20060014668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Antigenic gp 100 compounds for therapy and diagnosis and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/119502 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23449 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014668.pdf [firstpage_image] =>[orig_patent_app_number] => 11119502 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119502
Antigenic gp 100 compounds for therapy and diagnosis and methods of using same Apr 28, 2005 Abandoned
11/090437 Methods of diagnosing, preventing and treating cancer metastasis Mar 24, 2005 Abandoned
Array ( [id] => 7068950 [patent_doc_number] => 20050244333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Humanized anti-CEA T84.66 antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/077978 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10669 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244333.pdf [firstpage_image] =>[orig_patent_app_number] => 11077978 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/077978
Humanized anti-CEA T84.66 antibody and uses thereof Mar 10, 2005 Issued
Array ( [id] => 7216890 [patent_doc_number] => 20050260217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof' [patent_app_type] => utility [patent_app_number] => 11/071062 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11658 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260217.pdf [firstpage_image] =>[orig_patent_app_number] => 11071062 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/071062
Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof Mar 2, 2005 Abandoned
Array ( [id] => 7169718 [patent_doc_number] => 20050202485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Method and compositions for detection of liver cancer' [patent_app_type] => utility [patent_app_number] => 11/064760 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5636 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202485.pdf [firstpage_image] =>[orig_patent_app_number] => 11064760 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/064760
Method and compositions for detection of liver cancer Feb 22, 2005 Abandoned
Array ( [id] => 7050717 [patent_doc_number] => 20050186604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Aberrant Myc/TIP60 interactions as a target for anti-cancer therapeutics' [patent_app_type] => utility [patent_app_number] => 11/044865 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13754 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186604.pdf [firstpage_image] =>[orig_patent_app_number] => 11044865 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/044865
Aberrant Myc/TIP60 interactions as a target for anti-cancer therapeutics Jan 26, 2005 Abandoned
Array ( [id] => 6983282 [patent_doc_number] => 20050153352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Cancer specific gene MG20' [patent_app_type] => utility [patent_app_number] => 11/031922 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13795 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153352.pdf [firstpage_image] =>[orig_patent_app_number] => 11031922 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/031922
Cancer specific gene MG20 Jan 6, 2005 Abandoned
Array ( [id] => 6951775 [patent_doc_number] => 20050226869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Compositions and methods for the treatment of tumor of hematopoietic origin' [patent_app_type] => utility [patent_app_number] => 11/020508 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 74191 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226869.pdf [firstpage_image] =>[orig_patent_app_number] => 11020508 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/020508
Compositions and methods for the treatment of tumor of hematopoietic origin Dec 20, 2004 Abandoned
Array ( [id] => 5771571 [patent_doc_number] => 20050267022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Identification of novel factors that block programmed cell death or apoptosis by targeting JNK' [patent_app_type] => utility [patent_app_number] => 11/000365 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 37756 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267022.pdf [firstpage_image] =>[orig_patent_app_number] => 11000365 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/000365
Identification of novel factors that block programmed cell death or apoptosis by targeting JNK Nov 28, 2004 Issued
Array ( [id] => 7110603 [patent_doc_number] => 20050208058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Compositions and methods for modulating cell division' [patent_app_type] => utility [patent_app_number] => 10/995795 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17587 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208058.pdf [firstpage_image] =>[orig_patent_app_number] => 10995795 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/995795
Compositions and methods for modulating cell division Nov 21, 2004 Abandoned
Array ( [id] => 6912317 [patent_doc_number] => 20050176075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Mdm2 splice variants' [patent_app_type] => utility [patent_app_number] => 10/980519 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20290 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176075.pdf [firstpage_image] =>[orig_patent_app_number] => 10980519 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980519
Mdm2 splice variants Nov 2, 2004 Issued
Array ( [id] => 7252115 [patent_doc_number] => 20050142538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Viral receptor protein' [patent_app_type] => utility [patent_app_number] => 10/926337 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19313 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142538.pdf [firstpage_image] =>[orig_patent_app_number] => 10926337 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926337
Viral receptor protein Aug 25, 2004 Abandoned
Array ( [id] => 6990859 [patent_doc_number] => 20050089896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Method to control tumor progression and invasiveness' [patent_app_type] => utility [patent_app_number] => 10/923543 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13480 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089896.pdf [firstpage_image] =>[orig_patent_app_number] => 10923543 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/923543
Method to control tumor progression and invasiveness Aug 19, 2004 Abandoned
Menu